Buy or sell Bigfoot Biomedical stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Bigfoot Biomedical Stock
Medical Device Company
About Bigfoot Biomedical Stock
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
Investors
Abbott Biotech Ventures
Cormorant Asset Management
Janus Capital Group
JDRF T1D Fund
Quadrant Capital Advisors
Senvest Capital
Visionnaire Ventures
Funding History
November 2014 | $2.0M |
---|---|
October 2016 | $35.5M |
December 2017 | $37.0M |
March 2018 | $18.0M |
January 2020 | $45.0M |
Management
Chief Executive Officer
Brewer Jeffrey
Chief Financial Officer
Brett Hale
Chief Operating Officer
Ian Hanson
Press
Business Wire - Jun, 2 2020
massdevice - Aug, 1 2019
medtechdive - Jan, 22 2019
drugdeliverybusiness - Jan, 7 2019
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase